免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

PubMed

Review of regulatory requirements for benefit-risk assessment for medical devices: uncovering existing methodologies.

PMID:42400285 ·

E, l, e, n, a, , S, c, h, e, l, l, e, r, ;, , J, u, l, i, a, , R, o, h, r, b, e, r, g, ;, , M, i, c, h, a, e, l, , D, ', A, g, o, s, t, o, ;, , M, a, t, t, h, i, a, s, , K, o, h, l

期刊Expert review of medical devices
年份
PMID42400285

摘要

A positive benefit-risk profile is a prerequisite for the market approval of medical devices. However, regulations are often criticized for providing limited information on benefit-risk assessment (BRA) despite growing expectations for quantitative methods. A clearer understanding of regulatory requirements, existing methodologies, and unresolved issues is needed. Relevant regulatory documents referencing BRA for medical devices were systematically identified, with a primary focus on the Europea

官方來源

在 PubMed 上查看 →

資料來自 PubMed / NCBI。全文與最新資訊請一律參閱官方紀錄。

↑